The Expert Committee on Drug Dependence (ECDD) leads the way in the 40th meeting of the World Health Organization (WHO) in which the ECDD will be reviewing and assessing the uses and harms of cannabis.
The latest meeting of the World Health Organization is being held only weeks before Canada is about to legalize recreational marijuana.
During this meeting, the ECDD is supposed to discuss the rescheduling of marijuana and to recommend the most appropriate classification to be applied internationally.
Let us remind you that the original scheduling happened way back in 1935, before World War II, and this classification was introduced by the League of Nations.
Medical cannabis patients and advocacy groups from Argentina, Mexico, Uruguay, France, Germany, New Zealand, the Netherlands, South Africa, and the United States are presenting to the world leaders in an effort to recommend changes in the international scheduling of these cannabis preparations and products.
The WHO has already ruled several weeks ago that Cannabidiol (CBD) by itself is not a harmful substance, which has very low risks and high medical value.
In short, the WHO found that there is growing evidence that cannabis has “some therapeutic potential” to treat these conditions.
“The current international policies on cannabis are outdated and are having a detrimental impact on patients in the United States and worldwide,” said Steph Sherer, Executive Director of Americans for Safe Access, “Furthermore these policies do not reflect the reality of over 30 countries globally that have passed medical cannabis laws.”
This review and assessment of medical marijuana are probably the first steps in what is to become a true global movement.
Assuming that the results of this review are in favor of marijuana, the next step will be making a recommendation to UN Secretary-General Guterres to change international cannabis laws.
Seeing how Guterres is also the Prime Minister of Portugal, which started dealing with its drug problems almost 20 years ago, it seems that Guterres will be in favor of this review as well.